Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ATP2B1 |
| Upstream (Parents) |
|---|
| (<<) ALPP → ATP2B1 |
| (<<) ASB1 → ATP2B1 |
| (<<) CASP7 → ATP2B1 |
| (<<) CDKN2A → ATP2B1 |
| (<<) CHI3L1 → ATP2B1 |
| (<<) HLA-F → ATP2B1 |
| (<<) ICAM1 → ATP2B1 |
| (<<) KLF4 → ATP2B1 |
| (<<) LTB → ATP2B1 |
| (<<) MTHFD2 → ATP2B1 |
| (<<) RBP1 → ATP2B1 |
| (<<) RCOR1 → ATP2B1 |
| (<<) RPA4 → ATP2B1 |
| (<<) TCEB1 → ATP2B1 |
| Downstream (Children) |
|---|
| ATP2B1 → EP300 (>>) |
| ATP2B1 → GDNF (>>) |
| ATP2B1 → KRTAP1-3 (>>) |
| ATP2B1 → NPAS3 (>>) |
| ATP2B1 → WNT7A (>>) |
